THOR指數輪換ETF THIR 深 滬
已收盤 07-02 16:00:00 美东时间
34.21
+0.030
+0.09%
華盛通- 最 高34.48
- 今 開34.33
- 成交量 1.84万股
- 最 低 33.99
- 昨 收 34.18
- 總市值 2.17亿
- 52周最高 35.00
- 市盈率 靜 --
- 換手率 0.29%
- 52周最低 29.0366
- 委 比 0.00%
- 總股本 634.07万
- 歷史最高 35.00
- 量 比 0.38
- 振 幅 1.43%
- 歷史最低 23.9466
- 每 手 1
- 風險率 1.41%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BRIEF-BT CEO Allison Kirkby Says Could Possibly Bring In Third Parties At Some Point In Future
BRIEF-BT CEO Allison Kirkby Says Could Possibly Bring In Third Parties At Some Point In Future June 29 (Reuters) - BT Ceo Allison Kirkby JOINT VENTURE WITH VERIZON FOR MULTINATIONALS ‘COULD BE THE START OF FURTHER CONSOLIDATION’ ‘WE COULD POSSIBLY LOOK TO BRING IN THIRD PARTIES AT SOME POINT IN FUTU
06-29 14:46
UPDATE 2-Equinor to boost gas production from Norway's Troll gas field
UPDATE 2-Equinor to boost gas production from Norway's Troll gas field Companies investing $410 million to expand output Startup of new wells expected in 2028 Owners are Equinor, Petoro, Shell, TotalEnergies, ConocoPhillips Norway is Europe's biggest gas supplier Adds background on Norway production
06-19 15:15
BRIEF-Uranium Energy Corp Reports Results For The Third Quarter Of Fiscal 2026
BRIEF-Uranium Energy Corp Reports Results For The Third Quarter Of Fiscal 2026 June 9 (Reuters) - Uranium Energy Corp UEC.A : URANIUM ENERGY CORP REPORTS RESULTS FOR THE THIRD QUARTER OF FISCAL 2026 URANIUM ENERGY - Q3 PRODUCTION OF 32,195 LBS URANIUM CONCENTRATE AT TOTAL COST PER POUND OF $54.61 S
06-09 18:29
BRIEF-Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses
BRIEF-Grail Reports Full Results From Nhs-Galleri Trial Demonstrating Substantial Reduction In Stage Iv Cancer Diagnoses May 30 (Reuters) - Grail Inc GRAL.O : GRAIL REPORTS FULL RESULTS FROM NHS-GALLERI TRIAL DEMONSTRATING SUBSTANTIAL REDUCTION IN STAGE IV CANCER DIAGNOSES AT 2026 ASCO ANNUAL MEETIN
05-30 20:14
BRIEF-Replimune Gets Third Try At FDA Approval After Makary Departure- WSJ
BRIEF-Replimune Gets Third Try At FDA Approval After Makary Departure- WSJ May 29 (Reuters) - REPLIMUNE GETS THIRD TRY AT FDA APPROVAL AFTER MAKARY DEPARTURE- WSJ REPLIMUNE EXPECTED TO ANNOUNCE AGREEMENT WITH FDA TO RESUBMIT ITS ADVANCED MELANOMA TREATMENT FOR APPROVAL - WSJ Source text: [ https://t
05-29 19:33
BRIEF-Dexcom Uncovers Theft Of Scrapped Product, Notifies Potentially Impacted Users
BRIEF-Dexcom Uncovers Theft Of Scrapped Product, Notifies Potentially Impacted Users May 26 (Reuters) - Dexcom Inc DXCM.O : DEXCOM UNCOVERS THEFT OF SCRAPPED PRODUCT, NOTIFIES POTENTIALLY IMPACTED USERS DEXCOM INC - IDENTIFIES STOLEN LOTS OF G7 SENSORS SOLD BY THIRD PARTIES DEXCOM INC - SALES OF STO
05-26 21:46
BRIEF-QatarEnergy Acquires Interests In New Exploration Blocks Offshore Uruguay
BRIEF-QatarEnergy Acquires Interests In New Exploration Blocks Offshore Uruguay May 20 (Reuters) - QatarEnergy [RIC:RIC:QATPE.UL]: QATARENERGY - QATARENERGY ACQUIRES INTERESTS IN NEW EXPLORATION BLOCKS OFFSHORE URUGUAY QATARENERGY - UNDER THE AGREEMENTS, QATARENERGY HAS ACQUIRED AN 18% INTEREST IN B
05-20 14:19
BRIEF-Fagron Update On Fda Communication Regarding 2025 Inspection
BRIEF-Fagron Update On Fda Communication Regarding 2025 Inspection May 15 (Reuters) - Fagron NV FAGRO.BR : COMPANY RECEIVED A WARNING LETTER FROM FDA ON MAY 12, 2026 ASSOCIATED WITH DRUG PRODUCTS PRODUCED AT FACILITY USING IV BAGS SUPPLIED BY A THIRD-PARTY MANUFACTURER PRODUCTION AT BOSTON FACILITY
05-15 13:40
T1 Energy Q1 net loss widens on lower third-party fees
T1 Energy Q1 net loss widens on lower third-party fees Overview US solar and battery supply chain builder's Q1 net income from continuing ops reached record high Company's Q1 net loss widened due to discontinued operations losses T1 completed upsized convertible note offering to fund Austin solar ce
05-12 18:10
QUOTE BOX-Global finance leaders flag shifting capital flows, AI impact at Milken
QUOTE BOX-Global finance leaders flag shifting capital flows, AI impact at Milken Updates dateline, adds quotes May 5 (Reuters) - Top global investors and executives gathered at the Milken Institute Global Conference in Beverly Hills on Monday to discuss geopolitical tensions, private credit risks a
05-05 20:46
